Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00389142 · ClinicalTrials.gov registry record

Identifying Genetic Causes of IC/BPS

A clinical trial of Interstitial Cystitis and Bladder Pain Syndrome, sponsored by Boston Children's Hospital.

Recruiting
Registry status
1,000
Enrollment target
1
Study location

NCT00389142 is a study of Interstitial Cystitis and Bladder Pain Syndrome that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 1,000 participants, above the 324-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (209% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00389142, a study of Interstitial Cystitis and Bladder Pain Syndrome, is actively recruiting participants, sponsored by Boston Children's Hospital.

RECRUITING
Registry status
1,000 participants
Enrollment target
1
Study location

Study Summary

Interstitial cystitis (IC), also called Bladder Pain syndrome (BPS) is a common condition with no known cause or cure. Twin studies and family accounts have suggested that the condition may be genetic or passed down (inherited) from one generation to another. In this study, the investigators are collecting genetic material via blood or saliva and medical information from families in North America in an attempt to identify genetic factors that may cause IC/BPS. The investigators are enrolling inviduals with IC/BPS and their family members (family members with and without IC like symptoms). Travel to Boston not required.

Study Locations (1)

Massachusetts

  • Boston Children's Hospital (BCH) - Boston

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2006-01-15
Est. Completion 2030-12-31

Sponsor

Boston Children's Hospital

462 total trials

What the Registry Record Tells You About NCT00389142

The ClinicalTrials.gov registry entry for NCT00389142 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 324-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (209% higher). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Interstitial Cystitis appearing as the primary indexed condition, and to 0 interventions.

NCT00389142 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00389142 about?

NCT00389142 is a clinical study titled "Identifying Genetic Causes of IC/BPS". Interstitial cystitis (IC), also called Bladder Pain syndrome (BPS) is a common condition with no known cause or cure. Twin studies and family accounts have suggested that the condition may be genetic or passed down (inherited) from one generation to another. In this study, the investigators are co...

What is the current status of trial NCT00389142?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2006-01-15. Estimated completion is 2030-12-31.

What conditions does trial NCT00389142 study?

This clinical trial studies the following conditions: Interstitial Cystitis, Bladder Pain Syndrome.

Who is sponsoring clinical trial NCT00389142?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00389142 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Interstitial Cystitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.